The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2026 / June / How Zealand Pharma Is Scaling Quality Without Complexity
Bioprocessing Interviews Technology & Manufacturing Digital Technologies Quality & Compliance Regulation & Standards Standards & Regulation Sponsored

How Zealand Pharma Is Scaling Quality Without Complexity

How connected quality systems can help growing biotechs remain agile.

06/29/2026 0 min read Video

Share

As biotech companies grow, so does the complexity of their quality processes. How can teams expand without creating disconnected systems, duplicated work, and barriers for users?

Kamilla Vagtborg, Director and Head of Quality Systems at Zealand Pharma, explains how bringing documents, training, quality processes, and validation into one ecosystem can improve transparency and make information easier to navigate. She also discusses the value of investing in the right infrastructure early while keeping systems simple and adaptable as the organization evolves.

Watch the interview.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

Musings from The Power List: Michael May
Cell & Gene Development & Clinical Interviews
Musings from The Power List: Michael May

September 22, 2026

5 min read

CCRM CEO Michael May on quantum computing, commercialization, and the next era of cell therapy

The Barriers Limiting Radiopharmaceutical Access
Outsourcing Supply Chain Interviews
The Barriers Limiting Radiopharmaceutical Access

September 21, 2026

5 min read

From isotope supply to reimbursement, the practical challenges shaping real-world delivery in oncology

Musings from The Power List: Dajun Yang
Small Molecules Development & Clinical Interviews
Musings from The Power List: Dajun Yang

September 15, 2026

4 min read

The Ascentage Pharma CEO on why next-generation small molecules are expanding into territory once reserved for biologics

Musings from The Power List: Ali Tavassoli
Small Molecules Drug Discovery Development & Clinical
Musings from The Power List: Ali Tavassoli

September 10, 2026

8 min read

Ali Tavassoli explains how cyclic peptides and new discovery tools are opening up once-inaccessible biology

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: